Overview
Yelena Pristyazhnyuk is a Hematologist Oncology specialist and a Hematologist in Hartford, Connecticut. Dr. Pristyazhnyuk is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Deep Vein Thrombosis, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma (DLBCL).
Her clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
80 Seymour St, Hartford, CT 06102
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Yale University
Scott Huntington is a Hematologist Oncology specialist and an Oncologist in New Haven, Connecticut. Dr. Huntington has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Yale University
Iris Isufi is a Hematologist Oncology specialist and a Hematologist in New Haven, Connecticut. Dr. Isufi is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Mantle Cell Lymphoma (MCL), and Bone Marrow Transplant.
Syed Bilgrami is a Hematologist Oncology specialist and a Hematologist in Hartford, Connecticut. Dr. Bilgrami is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Deep Vein ThrombosisDr. Pristyazhnyuk isAdvanced. Learn about Deep Vein Thrombosis.
- Hodgkin LymphomaDr. Pristyazhnyuk isAdvanced. Learn about Hodgkin Lymphoma.
- Non-Hodgkin LymphomaDr. Pristyazhnyuk isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Pristyazhnyuk isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Pristyazhnyuk isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Mountain SicknessDr. Pristyazhnyuk isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Pristyazhnyuk isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Pristyazhnyuk isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Pristyazhnyuk isExperienced. Learn about Acute Myeloid Leukemia (AML).